Skip to main content
Clinical Trials/IRCT2014062718187N2
IRCT2014062718187N2
Completed
未知

The comparision of the effects of Micosin vaginal cream and Metronidazole vaginal gel on treatment of bacterial vaginosis

Research Council of Shiraz University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Vginosis Bacterial.
Sponsor
Research Council of Shiraz University of Medical Sciences
Enrollment
120
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Research Council of Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Those who are willing to cooperate; Married women of reproductive age (18 to 44 years old); Positive, Gram staining of bacterial vaginosis; Bacterial vaginosis symptoms on clinical examination; Non\-current use of anti\-parasitic drugs, antibiotics, immunosuppressive drugs and vaginal medications during the past two weeks; Lack of abnormal uterine bleeding; Not having recurrent vaginitis (4 or more than 4 times a year) ;No pregnancy; No breastfeeding; No use douching frequently; No alcohol and anticoagulant coumarin; No cases of multiple sex partners; No getting certain diseases, such as liver disease, diseases of the central nervous system, blood Dyscrasia, diabetes, immune deficiency; No history of allergy to mint category and garlic taken orally or topically.
  • Exclusion criteria: Sensitivity to the drug and non\-drug use; taking any prescribed medications with conflicting effect with medicines in this study; taking any drug that affect vaginosis symptoms and treatment; lack of patients interest

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Effect of Micosin vaginal cream compared to Miconazole vaginal cream for the treatment of mycotic vaginitiscandidiasis vaginitis.Candidiasis of vulva and vaginaB37.3+
IRCT2013120715697N1Vice chancellor for Research; Islamic Azad University of Rasht120
Completed
Phase 2
comparative evaluation of the effect of misoprostol vaginal suppository to vaginal misoprostol with nitroglycerine in rippening of cervix in term pregnancy reffered to kowsar hospital
IRCT20120428009576N4Qazvin University of Medical Sciences106
Not yet recruiting
Phase 3
Comparison of two different vaginal preparations of progesterone for prevention of recurrent preterm birth: A Randomized Controlled TrialHealth Condition 1: O092- Supervision of pregnancy with other poor reproductive or obstetric history
CTRI/2023/01/048696Post Graduate Institute of Medical Education and Research
Not yet recruiting
Not Applicable
Comparing a vaginal tablet (Misoprostol) and device (Dilapan) kept inside the cervix for dilatation of cervix before operative hysterosocpic proceduresHealth Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified
CTRI/2020/04/024844Jawaharlal Institute of Postgraduate Medical Education and Research
Completed
Phase 2
Comparison the effect of vaginal Misoprostol and vaginal Isoniazid for cervical ripening prior to hysteroscopy proceduresAbnormal uterine and vaginal bleeding, unspecified.Abnormal uterine and vaginal bleeding, unspecified
IRCT2015112821506N4Iran University of Medical Sciences100